References
- Raedler A, Scheiber S. Immunology of ulcerative colitis. Hepatogastroenterology 1989; 36: 213–8
- Gebbers J-O, Otto HF. Immunohistochemical and electronmi-croscopic observations on the local response in ulcerative colitis. Virchows Arch [Pathol Anat] 1977; 374: 271–3
- Nielsen OH. In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macropahges-with special reference to chronic inflammatory bowel disease. Scand J Gastroenterol 1988; 23: 1–21, Suppl 150
- Hume DA, Doe WF. Role of macrophages in cellular defense. Immunology of the gastrointestinal tract and the liver, MF Heyworth, AL Jones. Raven Press Ltd, New York 1988; 23–45
- Kunkel SL, Strieter RM, Chensue SW, Basha M, Standiford T, Ham J, et al. Tumor necrosis factor a, interleukin-8 and chemotactic cytokines. Prog Clin Biol Res 1990; 349: 433–44
- Larsen CG. Leukocyte activating and chemotactic cytokines in cell-mediated immune reactions of the human skin. Acta Dermato Venereol 1991; 1–48, Suppl 160
- Izutani R, Loh EY, Reinecker HC, Ohno Y, Fusunyan RD, Lichtenstein GR, et al. Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflam Bowel Dis 1995; 1: 37–47
- Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. Interleukin-8 as an important chemoattrac-tant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994; 96: 432–6
- Jones SC, Evans SW, Lobo AJ, Ceska M, Axon ATR, Whicher JT. Serum interleukin-8 in inflammatory bowel disease. J Gastroenterol Hepatol 1993; 8: 508–12
- Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994; 144: 997–1007
- Olsen JE, Doe WF. Quantitation of chemokine mRNA expression in inflammatory bowel disease mucosa. Gastroenterology 1995; 108: A888
- Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991; 26: 1247–56
- Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609–14
- Søltoft J, Gudmand-Høyer E, Krag E, Kristensen E, Wulff HR. A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet 1976; 1: 270–1
- Standiford TJ, Kunkel SL, Rolfe MW, Evanoff HL, Allen RM, Streiter RM. Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. Am J Cell Moll Biol 1992; 6: 75–81
- Mukaida N, Gusella GL, Kasahara T, Ko Y, Zachariae COC, Kawai T, et al. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. Immunology 1992; 75: 674–9
- Tvede M, Bondesen S, Nielsen OH, Rasmussen SN. Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol 1983; 18: 783–9
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156–9
- Markvadsen P, Bjerke T, Rüdiger N, Schiøtz PO, Gregersen N, Justesen J, et al. A PCR based method for the quantitation of transcript (mRNA) of interleukin-8 in human basophil leucocytes. Scand J Clin Lab Invest 1995; 55: 487–93
- Paludan K, Thestrup-Pedersen K. Use of polymerase chain reaction in quantification of interleukin-8 mRNA in minute epidermal samples. J Invest Dermatol 1992; 99: 830–5
- Nielsen OH, Kóppen T, Rüdiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996; 41: 1786–93
- Kornbluth A, Salomon P, Sachar DB, Jewell DP. Crohn's disease and ulcerative colitis. Gastrointestinal disease, MH Sleisenger, JS Fordtran. WB Saunders, Philadelphia 1993; 1270–330
- Raab Y, Gerdin B, Ahlstedt S, Hällgren R. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993; 34: 1203–6
- Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C. Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol 1993; 28: 296–300
- Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein Ml, Pellecchia C. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 1447–52
- Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1\interIeukin-8 in active ulcerative colitis. Clin Sci 1992; 82: 273–5
- Sher ME, A'Angelo AJ, Stein TA, Bailey B, Burns G. Cytokines in Crohn's colitis. Am J Surg 1995; 169: 133–6
- Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38: 216–22
- Grimm MC, Elsbury SKO, Pavli P, Doe WF. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996; 38: 90–8
- Isaacs KL, Sartor R, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587–95
- Wang P, Wu P, Anthes JC, Siegel MJ, Egan RW, Billah MM. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994; 83: 2678–83